Research and specialist diagnostic molecular services

We are a biomedical company with extensive experience in the molecular diagnostic field that allows us to improve the patient’s life quality by putting genetics at their service.

Research and specialist diagnostic molecular services

We are a biomedical company with extensive experience in the molecular diagnostic field that allows us to improve the patient’s life quality by putting genetics at their service.

“In situ” hybridization (FISH)

Highly sensitive technique that allows us to detect chromosomal alterations (number of copies of a gene or a chromosomal rearrangements) in different neoplasms for diagnosis and/or targeted treatment, using probes labeled with a fluorochrome.

Molecular Biology

Molecular biology tools allow us to specifically detect and quantify the genetic material in a biological sample, having a great impact on both the diagnosis of cancer and hereditary and infectious diseases. The appearance of new faster and more precise techniques (arrays or NGS), allow us to perform global genomic analyzes in a short period of time.

News

ENCORAFENIB PLUS CETUXIMAB AS A NEW STANDARD OF

BEACON CRC evaluated encorafenib plus cetuximab with or without binimetinib versus investigators’ choice of

FDA APPROVES PEMBROLIZUMAB FOR ADVANCED OR METASTATIC ESOPHAGEAL/GASTROESOPHAGEAL

The United States Food and Drug Administration (FDA) has granted approval for Merck’s anti-programmed

RISK ASSESSMENT FOR DISTANT METASTASIS IN DIFFERENTIATED THYROID

The authors of this case–control study compared the ThyroSeq genetic profiles of 62 patients

VALIDATION OF A 22-GENE GENOMIC CLASSIFIER IN PATIENTS

In this ancillary analysis of the RTOG 9601 study, the researchers validated a 22-gene

6Q DELETION IN WALDENSTRÖM MACROGLOBULINAEMIA NEGATIVELY AFFECTS TIME

Deletion of the long arm of chromosome 6 (del6q) is the most frequent cytogenetic

follow us

Do you need any of our services?

Write us